- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT05328739
The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers
The Effect of Planned Homecare According to Orem on the Self-care Agency and Care Burden in Patients With Primary Brain Tumors and Caregivers: A Randomized Controlled Trial
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Eyalet/Yerleşke
-
Kayseri, Eyalet/Yerleşke, Krocan, 38260
- Erciyes University Faculty of Health Science
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
inclusion criteria for patient;
- living within the borders of the region,
- being over 18 years old,
- being at least literate, being able to communicate in Turkish,
- being oriented to person, place and time, not having hearing and speaking problems,
- having primar brain tumor (glial or meningeal) surgery,
- taking part in grade I, II, III
- and having Karnovsky Performance Scale (KPS) score above 50 points.
exclusion criteria for patient;
- being under the age of 18,
- illiterate, unable to communicate in Turkish,
- being diagnosed with a neurological and psychiatric disorder that may affect the cognitive status,
- not being oriented to the person, place and time, having hearing and speaking problems,
- having surgery for a metastatic brain tumor,
- having surgery for a pituitary adenoma, to have undergone emergency surgery, to have a biopsy,
- to be in grade IV,
- to have a KPS score below 50 points.
Criteria for terminating the research process;
- wanting to leave the research process,
- meeting one of the criteria for exclusion from the sample after the surgery,
- spending the home care and follow-up process in another province, and/or not being able to reach the individual.
inclusion criteria for caregiver;
- being over the age of 18,
- being literate, being able to communicate in Turkish, and not having hearing and speaking problems,
- caring for a patient who had primary brain tumor surgery.
exclusion criteria for caregiver ;
- being under the age of 18,
- illiterate, unable to communicate in Turkish,
- being diagnosed with a neurological or psychiatric disorder that may affect the cognitive status,
- and having hearing and speech problems.
Criteria for terminating the research process;
- wanting to leave the research process,
- meeting one of the criteria for exclusion from the sample after the surgery,
- spending the home care and follow-up process in another province, and/or not being able to reach the individual.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Experimentální: Home care group
The home care program included education, counseling and nursing care to determine and meet the self-care/dependant care needs of patients and caregivers at home after brain surgery. At preoperative period (PRP) an average of 90-120 minutes of training was given to both the patient and the caregiver until the patient was discharged. At this stage, the training was carried out in order to prepare the patient and caregiver for the transition to home. At postoperative period (POP) two home visits were made within the first month following the discharge, planned for education, counseling and nursing care. The first home visit was made in the first week after discharge (10-18 days after surgery), and the second home visit was made 30-40 days after surgery. Then, in the home visits made once in the 2nd, 3rd and 4th months.No home visits were made between the 4th-month attempt and the 6th month, but telephone counseling was provided when necessary. Home visits ranged from 60 to 120 minutes. |
home care program
|
Žádný zásah: Control group
The patient received routine care in the hospital until discharge.
Three home visits were made to collect the data of patients and caregivers in the 1st and 3rd and 6th months of POP after discharge, but no intervention was made.
The visits took about 30-45 minutes.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Self-Care Agency Scale (SCAS) Mean Score
Časové okno: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
SCAS: in order to evaluate the self-care agency of patients and caregiver each measurement was performed before the intervention at the time.
The lowest score is 35, the highest score is 140.
The highest score shows the greatest degree of self-care agency.Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
MD Anderson Symptom Inventory Brain Tumor-Turkish Form (MDA-BTSETr ) Mean Score
Časové okno: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
MDA-BTSETr: in order to evaluate the symptoms and the impact of the symptoms on the lives of patients, each measurement was performed before the intervention at the time.
The inventory consists of two parts that evaluate the symptoms and the interference of the individual's life.
In the first part of the inventory, individuals are asked to rate the severity of each symptom in the last 24 hours between 0-10 (0: no symptom, 10: the most severe level of the symptom experienced).
In the second part, individuals are asked to rate how much their symptoms interfere with their lives, from 0 to 10 (0: not interfered, 10: completely interfered).Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Caregiver Burden Scale (CBS) Mean Score
Časové okno: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
CBS: in order to evaluate the care burden of individuals who care for patients who have undergone primary brain tumor surgery, each measurement was performed before the intervention at the time.
The lowest score that can be obtained from the scale is 0, the highest score is 88, and an increasing score indicates an increase in the burden of care.Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Karnofsky Performance Scale (KPS) Mean Score
Časové okno: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
KPS allows to determine the individual and medical care needs of the patient, to obtain information about symptom severity and level of function at work and home.
It is scored between 0-100.
The loss of function from normal function (100) to death (0) based on the functional status of the individual.
Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Derya Dağdelen, PhD, TC Erciyes Universty
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 2019/179
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na home care
-
National University, SingaporeNational University Hospital, SingaporeDokončeno
-
Chunrui LiNanjing IASO Biotechnology Co., LtdNáborStudie CAR-GPRC5D u pacientů s relapsem/refrakterním mnohočetným myelomem nebo plazmatickou leukémiíPlazmabuněčná leukémie | Recidivující/refrakterní mnohočetný myelomČína
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityDokončenoRefrakterní difúzní velký B-buněčný lymfomČína
-
Daniel LandiUkončenoGlioblastom | GliosarkomSpojené státy
-
Nexcella Inc.Zatím nenabírámeAmyloidóza lehkého řetězce (AL).Spojené státy
-
Second Affiliated Hospital, School of Medicine,...NáborRecidivující a refrakterní B-buněčný lymfomČína
-
Second Affiliated Hospital, School of Medicine,...NáborB-buněčný non Hodgkinův lymfomČína
-
Hebei Senlang Biotechnology Inc., Ltd.NáborLymfom | Mnohočetný myelom | Akutní lymfoblastická leukémieČína
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...StaženoAkutní lymfoblastická leukémie | Non-hodgkinský lymfomSpojené státy
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalNáborStudie CAR-GPRC5D u pacientů s relapsem/refrakterním mnohočetným myelomem nebo plazmatickou leukémiíPlazmabuněčná leukémie | Recidivující/refrakterní mnohočetný myelomČína